Results 21 to 30 of about 263,626 (317)

Drug Repurposing for Parkinson’s Disease: The International Linked Clinical Trials experience

Frontiers in Neuroscience, 2021
The international Linked Clinical Trials (iLCT) program for Parkinson’s to date represents one of the most comprehensive drug repurposing programs focused on one disease.
Simon R. W. Stott, Richard K. Wyse, Patrik Brundin   +2 more
doaj   +1 more source

Parkinson's disease - psychological determinants of quality of life [PDF]

, 2010
There are many studies, which are focused on measurement the quality of life (QoL) of patients with Parkinson’s disease (PD), but studies about psychological factors associated with QoL in those patients are scarce.
Dubayova, Tatiana,, Dubayova, Tatiana
core   +1 more source

Measuring anxiety in Lewy Body Disease – Which scale to choose?

Clinical Parkinsonism & Related Disorders, 2021
Background: Anxiety is among the most prevalent mood disorders in Lewy Body Disease (LBD) (i.e., Parkinson’s disease (PD), Dementia with Lewy bodies DLB), and those at-risk for developing LBD (e.g. isolated REM Sleep Behaviour Disorder (iRBD)).
Isabel Paniak, Simon J.G. Lewis, Kaylena A. Ehgoetz Martens   +2 more
doaj   +1 more source

Additional file 2: of Responsiveness of the short-form health survey and the Parkinsonâ s disease questionnaire in patients with Parkinsonâ s disease

, 2017
Internal responsiveness of HRQoL in the stable patient group. (DOCX 20 kb)
Tu, Xiao-Jing, Wen-Juh Hwang, Shih-Pin Hsu, Hui-Ing Ma   +3 more
openaire   +1 more source

Auditory observation of stepping actions can cue both spatial and temporal components of gait in Parkinson's disease patients [PDF]

, 2014
Objectives: A common behavioural symptom of Parkinson’s disease (PD) is reduced step length (SL). Whilst sensory cueing strategies can be effective in increasing SL and reducing gait variability, current cueing strategies conveying spatial or temporal ...
Young, William R., Rodger, Matthew W. M.; id_orcid, Rodger, MWM, Craig, CM, Rodger, Matthew W.M., Craig, Cathy M., Young, WR   +6 more
core   +1 more source

MOESM2 of White matter damage and systemic inflammation in Parkinsonâ s disease

, 2017
Additional file 2: Partial correlation between DTI indices and clinical disease severity.
Chiang, Pi-Ling, Chen, Hsiu-Ling, Lu, Cheng-Hsien, Chen, Pei-Chin, Chen, Meng-Hsiang, Yang, I.-Hsiao, Tsai, Nai-Wen, Lin, Wei-Che   +7 more
openaire   +1 more source

MOESM1 of White matter damage and systemic inflammation in Parkinsonâ s disease

, 2017
Additional file 1: Supplementary methods of DTI data preprocessing and analysis.
Chiang, Pi-Ling, Chen, Hsiu-Ling, Lu, Cheng-Hsien, Chen, Pei-Chin, Chen, Meng-Hsiang, Yang, I.-Hsiao, Tsai, Nai-Wen, Lin, Wei-Che   +7 more
openaire   +1 more source

Morphological changes of glutamatergic synapses in animal models of Parkinson’s disease

Frontiers in Neuroanatomy, 2015
The striatum and the subthalamic nucleus are the main entry doors for extrinsic inputs to reach the basal ganglia circuitry. The cerebral cortex, thalamus and brainstem are the key sources of glutamatergic inputs to these nuclei.
Rosa M Villalba, Rosa M Villalba, Abraham eMathai, Abraham eMathai, Yoland eSmith, Yoland eSmith, Yoland eSmith   +6 more
doaj   +1 more source

Association between changes in visual evoked magnetic fields and non-motor features in Parkinson’s disease [PDF]

, 2017
2017-05Visual dysfunction can be caused by several abnormalities, including dysfunctions in the visual cortex and retina. Our aim was to investigate changes in visual evoked brain responses in the primary visual cortex associated with Parkinson’s disease
Uemura, Jun-ichi, Minato, Tomomi, Hoshiyama, Minoru, Hirayama, Masaaki, Fujisawa, Yoshiro, Watanabe, Hirohisa   +5 more
core   +1 more source

Additional file 1: of Cerebellar involvement in Parkinsonâ s disease resting tremor

, 2016
Summary Analysis Data. (DOCX 13 kb)
Lefaivre, Shannon, Brown, Matt, Almeida, Quincy   +2 more
openaire   +1 more source